Talphera (TLPH) Depreciation & Amortization (CF) (2010 - 2023)

Talphera's (TLPH) quarterly Depreciation & Amortization (CF) came in at $49000.0 in Q2 2023, down 89.37% year-on-year from $461000.0 in Q2 2022, and down 81.3% quarter-over-quarter from $262000.0 in Q1 2023.

Talphera (TLPH) Depreciation & Amortization (CF) (2010 - 2023) Analysis & Trends

Talphera's Depreciation & Amortization (CF) history runs 14 years deep, the most recent figure standing at $49000.0 for Q2 2023.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 89.37% year-over-year to $49000.0 in Q2 2023; TTM through Mar 2024 was $49000.0, a 96.71% decrease from a year earlier, with the FY2023 full-year figure at $311000.0, down 81.12% from the prior year.
  • Depreciation & Amortization (CF) slipped to $49000.0 in Q2 2023 per TLPH's latest filing, from $262000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $579000.0 in Q2 2021 and bottomed at $49000.0 in Q2 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $437000.0 (2021), against an average of $414000.0.
  • Across the five-year window, Depreciation & Amortization (CF) jumped 267.86% in 2019 and tumbled 89.37% in 2023, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $515000.0 in 2019, then declined by 25.83% to $382000.0 in 2020, then rose by 20.68% to $461000.0 in 2021, then declined by 25.81% to $342000.0 in 2022, then tumbled by 85.67% to $49000.0 in 2023.
  • Per Business Quant, the three latest TLPH Depreciation & Amortization (CF) figures stand at $49000.0 (Q2 2023), $262000.0 (Q1 2023), and $342000.0 (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Talphera 47.31 Mn 9.48 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 49,000.00
Jun 30, 2023 49,000.00
Mar 31, 2023 262,000.00
Mar 31, 2023 262,000.00
Dec 31, 2022 342,000.00
Dec 31, 2022 342,000.00
Sep 30, 2022 424,000.00
Sep 30, 2022 424,000.00
Jun 30, 2022 461,000.00
Jun 30, 2022 461,000.00
Mar 31, 2022 420,000.00
Mar 31, 2022 420,000.00
Dec 31, 2021 461,000.00
Dec 31, 2021 461,000.00
Sep 30, 2021 483,000.00
Sep 30, 2021 483,000.00
Jun 30, 2021 579,000.00
Jun 30, 2021 579,000.00
Mar 31, 2021 450,000.00
Mar 31, 2021 450,000.00